CQS
RMD icon

Credential Qtrade Securities’s ResMed RMD Stock Holding History

Credential Qtrade Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$33.2M Buy
167,465
+9,292
+6% +$1.7M 1.78% 20
2023
Q4 		$27.2M Buy
+158,173
New +$24.3M 1.62% 23

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credential Qtrade Securities's RMD Position: Q1 2024 in Review

Credential Qtrade Securities increased its ResMed (RMD) stake by 5.9% in Q1 2024, buying an estimated $1.7M and bringing the position to 167,465 shares worth $33.2M. The position accounts for 1.78% of the portfolio, ranked #20.

Credential Qtrade Securities first reported a position in RMD in Q4 2023 and has held it in 2 quarters since. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Credential Qtrade Securities held 167,465 shares of ResMed worth $33.2M as of Q1 2024.
  • Credential Qtrade Securities bought 9,292 ResMed shares in Q1 2024, an estimated $1.7M.
  • ResMed made up 1.78% of Credential Qtrade Securities's portfolio in Q1 2024, its #20 holding.
  • Credential Qtrade Securities first reported a position in ResMed in Q4 2023 and has held it in 2 quarters since.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.